Fraunhofer Institute for Toxicology and Experimental Medicine

Fraunhofer Research consortium iCAIR® makes use of synergies to develop new medications against SARS-CoV-2.

Munich Re and Fraunhofer have launched a global call for ideas to identify the best 3D-printable designs/blueprints for emergency ventilation equipment.

Responding to the worldwide situation related to COVID-19, the Society of Toxicology has canceled the SOT Annual Meeting scheduled to take place March 15–19, 2020.

What were our topics last year? Our Annual Report 2019 provides insights into our highlights, results, and service portfolio.

Thematic forum at Fraunhofer ITEM: new impetus for biomedical engineering 

Impressions of the 19^th Fraunhofer seminar "Models of Lung Disease" held on February 6 and 7, 2020.

Research at Fraunhofer ITEM is focused on human health – and this has been so for almost four decades.

The emphasis is on two aspects: firstly, on protecting health from potentially harmful, in particular airborne substances, be they gases, aerosols, particles, fibers, or nanomaterials, and secondly, on investigating and developing diagnostic and therapeutic approaches, both at the preclinical and clinical levels.

A special focus is on airway research.